Phase I clinical study of a new radiopharmaceutical based on recombinant target molecules DARPin9_29 labeled with technetium-99m for radionuclide diagnosis of the Her2/neu-positive breast cancer
Molekulyarnaya Meditsina (Molecular medicine)（2021）
关键词
recombinant target molecules darpin9_29,radionuclide diagnosis,breast cancer,neu-positive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要